Cutler Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,900
Closed -$1K 5825
2017
Q2
$1K Buy
+3,900
New +$147K ﹤0.01% 5776
2017
Q1
Sell
-25,700
Closed -$52K 6342
2016
Q4
$52K Buy
25,700
+17,300
+206% +$618K ﹤0.01% 2494
2016
Q3
$2K Buy
8,400
+3,400
+68% +$119K ﹤0.01% 5619
2016
Q2
$2K Buy
+5,000
New +$153K ﹤0.01% 5586
2016
Q1
Sell
-25,100
Closed -$14K 6452
2015
Q4
$14K Buy
+25,100
New +$780K ﹤0.01% 3752

Other funds holding AVNS

Cutler Group's AVNS Position: Q4 2018 in Review

Cutler Group sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 3,725 shares — an estimated $255K sold.

Cutler Group first reported a position in AVNS in Q4 2015 and held it in 9 quarters. The position peaked at $255K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Cutler Group reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Cutler Group sold 3,725 Avanos Medical shares in Q4 2018, an estimated $255K.
  • Cutler Group first reported a position in Avanos Medical in Q4 2015 and held it in 9 quarters.
  • Cutler Group's Avanos Medical position peaked at $255K in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Cutler Group's 13F filing for Q4 2018, filed 5 Feb 2019.